Parent Project Muscular Dystrophy
Non-Profit & Charitable Organizations · District of Columbia, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1012 14th St NW Ste 500, Washington, Dis...Phone Number
(800) 714-5437Website
www.parentprojectmd.orgRevenue
$7.3 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Parent Project Muscular Dystrophy
Parent Project Muscular Dystrophy (PPMD) is dedicated to ending Duchenne muscular dystrophy through research acceleration, advocacy for policy change, and ensuring optimal care for affected families. They provide resources and support for individuals diagnosed with Duchenne, their families, and healthcare professionals. PPMD also engages in fundraising initiatives and community events to raise awareness and funds for research and therapy development. Their mission includes improving access to approved therapies and fostering a supportive community for those impacted by Duchenne.Explore more
Parent Project Muscular Dystrophy Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Parent Project Muscular Dystrophy your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Parent Project Muscular Dystrophy has recently received funding, and reach out quickly before it becomes old news!
Check out if Parent Project Muscular Dystrophy is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Parent Project Muscular Dystrophy
Product Launch: Get notified when Parent Project Muscular Dystrophy launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Parent Project Muscular Dystrophy recently announced quarterly report
Click to see if Parent Project Muscular Dystrophy had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Parent Project Muscular Dystrophy has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Parent Project Muscular Dystrophy, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Parent Project Muscular Dystrophy
Compare insights from companies similar to Parent Project Muscular Dystrophy, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Parent Project Muscular Dystrophy is experiencing very low activity levels compared to other companies in the Organizations sector.
What does this means?
Parent Project Muscular Dystrophy is drawing exceptional interest within the Organizations industry, suggesting notable developments or strong market momentum, learn more about Parent Project Muscular Dystrophy.
Parent Project Muscular Dystrophy financials insights
Gather financial insights about Parent Project Muscular Dystrophy, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
2021
Debt
$425K
Parent Project Muscular Dystrophy Tech Stack
A closer look at the technologies used by Parent Project Muscular Dystrophy
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Executive Moves, Lateral Move
Project
Spending/Investment
Funding
Parent Project Muscular Dystrophy has received an SBA PPP loan in the amount of $425,852 from JPMorgan Chase resulting in the retention of 16 jobs.
Funding
Parent Project Muscular Dystrophy News & Media
Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION
Working with Parent Project Muscular Dystrophy and the Duchenne Registry on patient identification and trial awareness effortsMesoblast Receives IND Clearance from FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy
Partnering with Parent Project Muscular Dystrophy to ensure timely access to the trial for eligible patientsPPMD Provides $250,000 in Funding to Secretome Therapeutics Through PPMD Venture Pathways Program to Support Development of Cardiac Cell Therapy
WASHINGTON, March 24, 2026 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), the leading U.S. non-profit driving Duchenne and Becker muscular dystrophy care, research, and advocacy efforts, and Secretome Therapeutics (Secretome) are excited to announce that PPMD has provided...Parent Project Muscular Dystrophy, Foundation to Eradicate Duchenne Announce 2026 Advocacy Leadership Awards Recipients Honoring Bipartisan Champions in Congress
WASHINGTON, March 9, 2026 /PRNewswire/ -- Parent Project Muscular Dystrophy (PPMD), in partnership with the Foundation to Eradicate Duchenne (FED), today announced Representative Troy Balderson (OH-12), Senator Susan Collins (ME), Senator Amy Klobuchar (MN), Representative Doris Matsui...
Read more news
Top Non-Profit & Charitable Organizations Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Parent Project Muscular Dystrophy
Sign Up For FreeTo access detailed company insights
Parent Project Muscular Dystrophy (PPMD) is dedicated to ending Duchenne muscular dystrophy through research acceleration, advocacy for policy change, and ensuring optimal care for affected families. They provide resources and support for individuals diagnosed with Duchenne, their families, and healthcare professionals. PPMD also engages in fundrai... Read More
